Product Information

METFORMIN HCL 500 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0142 per EA under NDC 62135068090. Its NADAC has been published 206 times since Sep 14, 2022.

FDA first approved this application on Jan 24, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Metformin Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

METFORMIN HCL 500 MG TABLET

Metformin Hydrochloride
$0.0142per EA
High Outlier

Strength

500 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135068090

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075972

FDA Approved

1/24/2002

TE Code

AB

On Market Since

1/24/2002

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN HCL 500 MG TABLET has been published 206 times since Sep 14, 2022, and over the history we have for it it has declined 4.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0142 per EA
All-time high$0.0177 (Nov 16, 2022)
All-time low$0.0123 (Nov 20, 2024)
52-week high$0.0147
52-week low$0.0139
Median price$0.0146
Average price$0.0149
Largest weekly change+20.4% (Jun 19, 2024)
Weeks tracked206
Tracking sinceSep 14, 2022

Price History

1W

+0.9%

1M

+1.5%

3M

+1.6%

6M

+1.7%

1Y

-1.5%

3Y

-11.8%

5Y

N/A

All

-4.1%

Generic Alternatives

The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METFORMIN HCL 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 500 MG TABLET, manufactured by Chartwell RX LLC, is $0.0142 per EA (NDC 62135068090), effective Aug 19, 2026.

How has the price of METFORMIN HCL 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for METFORMIN HCL 500 MG TABLET has declined 4.1%. It has been tracked across 206 weekly CMS publications since Sep 14, 2022.

What are the highest and lowest recorded NADAC prices for METFORMIN HCL 500 MG TABLET?

Since Sep 14, 2022, the NADAC for METFORMIN HCL 500 MG TABLET has ranged from a low of $0.0123 (Nov 20, 2024) to a high of $0.0177 (Nov 16, 2022), with a median of $0.0146 per EA.

Are there cheaper alternatives to METFORMIN HCL 500 MG TABLET?

21 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL 500 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METFORMIN HCL 500 MG TABLET?

METFORMIN HCL 500 MG TABLET (NDC 62135068090) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.